Linked Life Data

16490756

Source:http://linkedlifedata.com/resource/pubmed/id/16490756

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2006-7-24
pubmed:abstractText
To find an effective, safe immunosuppressive regimen as an alternative to cyclophosphamide (Cy) for the treatment of clinically evident diffuse scleroderma (dSSc)-associated alveolitis of recent onset.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1462-0324
pubmed:author
pubmed:issnType
Print
pubmed:volume
45
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1005-8
pubmed:dateRevised
2007-9-6
pubmed:meshHeading
pubmed-meshheading:16490756-Adolescent, pubmed-meshheading:16490756-Adult, pubmed-meshheading:16490756-Anti-Inflammatory Agents, Non-Steroidal, pubmed-meshheading:16490756-Drug Therapy, Combination, pubmed-meshheading:16490756-Female, pubmed-meshheading:16490756-Glucocorticoids, pubmed-meshheading:16490756-Humans, pubmed-meshheading:16490756-Male, pubmed-meshheading:16490756-Middle Aged, pubmed-meshheading:16490756-Mycophenolic Acid, pubmed-meshheading:16490756-Prednisolone, pubmed-meshheading:16490756-Prospective Studies, pubmed-meshheading:16490756-Pulmonary Diffusing Capacity, pubmed-meshheading:16490756-Pulmonary Fibrosis, pubmed-meshheading:16490756-Scleroderma, Diffuse, pubmed-meshheading:16490756-Tomography, X-Ray Computed, pubmed-meshheading:16490756-Treatment Failure, pubmed-meshheading:16490756-Vital Capacity
pubmed:year
2006
pubmed:articleTitle
Mycophenolate mofetil as first-line treatment improves clinically evident early scleroderma lung disease.
pubmed:affiliation
Division of Rheumatology, Department of Internal Medicine, Patras University Hospital, 26504 Rion, Patras, Greece. sliossis@med.upatras.gr
pubmed:publicationType
Journal Article, Clinical Trial